Hiroshi Ida

3.4k total citations
90 papers, 2.5k citations indexed

About

Hiroshi Ida is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Hiroshi Ida has authored 90 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 33 papers in Epidemiology and 23 papers in Molecular Biology. Recurrent topics in Hiroshi Ida's work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Liver Disease Diagnosis and Treatment (26 papers) and Hepatitis C virus research (13 papers). Hiroshi Ida is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Liver Disease Diagnosis and Treatment (26 papers) and Hepatitis C virus research (13 papers). Hiroshi Ida collaborates with scholars based in Japan, Singapore and United States. Hiroshi Ida's co-authors include Naoshi Nishida, Yoshiaki Ito, Masatoshi Kudo, Satoru Hagiwara, Kazuomi Ueshima, Yasunori Minami, Masahiro Takita, Toshiharu Sakurai, Hirokazu Chishina and Kosei Ito and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Hiroshi Ida

87 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Ida Japan 27 990 883 553 531 530 90 2.5k
George Κ. Koukoulis Greece 26 516 0.5× 793 0.9× 831 1.5× 264 0.5× 570 1.1× 71 2.2k
Harald Rieder Germany 31 1.1k 1.1× 535 0.6× 309 0.6× 613 1.2× 1.2k 2.3× 84 3.5k
Edwin C. Douglass United States 31 1.5k 1.5× 446 0.5× 266 0.5× 368 0.7× 826 1.6× 70 3.3k
Hiroko Ikeda Japan 30 539 0.5× 670 0.8× 596 1.1× 400 0.8× 713 1.3× 130 2.5k
Irina A. Lubensky United States 26 1.1k 1.1× 202 0.2× 524 0.9× 652 1.2× 635 1.2× 41 2.2k
Luca Emanuele Pollina Italy 22 750 0.8× 495 0.6× 210 0.4× 566 1.1× 1.1k 2.1× 63 2.1k
J. Plaschkes Switzerland 25 657 0.7× 1.9k 2.2× 286 0.5× 445 0.8× 1.1k 2.1× 48 3.1k
József Zsíros Netherlands 18 443 0.4× 635 0.7× 125 0.2× 250 0.5× 657 1.2× 49 1.9k
Xiang‐Ming Lao China 26 401 0.4× 418 0.5× 333 0.6× 260 0.5× 1.0k 1.9× 56 2.1k
Pilar Lardelli Spain 19 298 0.3× 276 0.3× 334 0.6× 141 0.3× 643 1.2× 71 1.5k

Countries citing papers authored by Hiroshi Ida

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Ida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ida more than expected).

Fields of papers citing papers by Hiroshi Ida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ida. The network helps show where Hiroshi Ida may publish in the future.

Co-authorship network of co-authors of Hiroshi Ida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ida. A scholar is included among the top collaborators of Hiroshi Ida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ida. Hiroshi Ida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoki, Tomoko, Naoshi Nishida, Yutaka Kurebayashi, et al.. (2025). Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway. Clinical and Molecular Hepatology. 31(3). 981–1002. 3 indexed citations
2.
Hagiwara, Satoru, Hiroshi Ida, Takaaki Chikugo, et al.. (2024). Peliosis Hepatis Complicated by Scleroderma and Rapidly Progressing to Liver Failure. Internal Medicine. 63(23). 3171–3178.
3.
Morita, Masahiro, Naoshi Nishida, Tomoko Aoki, et al.. (2023). Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma. Cancers. 15(8). 2311–2311. 20 indexed citations
4.
Hagiwara, Satoru, Tomohiro Watanabe, Masatoshi Kudo, et al.. (2021). Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease. Scientific Reports. 11(1). 9242–9242. 14 indexed citations
5.
6.
Arizumi, Tadaaki, Tomohiro Minami, Hirokazu Chishina, et al.. (2017). Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2. Digestive Diseases. 35(6). 589–597. 42 indexed citations
7.
Arizumi, Tadaaki, Kazuomi Ueshima, Tomohiro Minami, et al.. (2017). The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization. Liver Cancer. 6(3). 227–235. 20 indexed citations
8.
Hagiwara, Satoru, Naoshi Nishida, Toshiharu Sakurai, et al.. (2017). Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis C. Digestive Diseases. 35(6). 548–555. 1 indexed citations
9.
Arizumi, Tadaaki, Tomohiro Minami, Hirokazu Chishina, et al.. (2017). Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2. Digestive Diseases. 35(6). 583–588. 9 indexed citations
10.
Nagai, Tomoyuki, Tokuzo Arao, Kazuto Nishio, et al.. (2016). Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma. Digestive Diseases. 34(6). 702–707. 17 indexed citations
11.
Yamada, Atsushi, Takahiro Horimatsu, Yoshinaga Okugawa, et al.. (2015). Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. Clinical Cancer Research. 21(18). 4234–4242. 131 indexed citations
12.
Arizumi, Tadaaki, Kazuomi Ueshima, Tomohiro Minami, et al.. (2015). Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma. Oncology. 89(Suppl. 2). 47–52. 31 indexed citations
13.
Nishida, Naoshi, Tadaaki Arizumi, Masahiro Takita, et al.. (2013). Quantification of Tumor DNA in Serum and Vascular Invasion of Human Hepatocellular Carcinoma. Oncology. 84(Suppl. 1). 82–87. 13 indexed citations
14.
Otsuka, Masayuki, et al.. (2012). STUDY OF MEASUREMENT PERFORMANCE EVALUATION WHEN FACES OF TOILETS WITH AN UROFLOWMETER ARE USED IN HOSPITAL FACILITY. AIJ Journal of Technology and Design. 18(39). 617–622. 1 indexed citations
15.
16.
Ido, Akio, Akihiro Moriuchi, Hiroyuki Marusawa, et al.. (2008). Translational research on HGF: A phase I/II study of recombinant human HGF for the treatment of fulminant hepatic failure. Hepatology Research. 38(s1). S88–92. 7 indexed citations
17.
Yazumi, Shujiro, Kohei Ogawa, Kazunori Hasegawa, et al.. (2008). Biliary Complications in Donors for Living Donor Liver Transplantation. The American Journal of Gastroenterology. 103(6). 1393–1398. 38 indexed citations
18.
Hasegawa, Kazunori, Shujiro Yazumi, Manabu Wada, et al.. (2007). Restoration of RUNX3 enhances transforming growth factor‐β‐dependent p21 expression in a biliary tract cancer cell line. Cancer Science. 98(6). 838–843. 18 indexed citations
19.
Ito, Ken‐ichi, Manuel Salto‐Tellez, T. Yano, et al.. (2006). RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization (vol 65, pg 7743, 2005). Cancer Research. 66. 3345–3345. 1 indexed citations
20.
Yamamura, Yasuko, Wei Lin Lee, Ken‐ichi Inoue, Hiroshi Ida, & Yoshiaki Ito. (2005). RUNX3 Cooperates with FoxO3a to Induce Apoptosis in Gastric Cancer Cells. Journal of Biological Chemistry. 281(8). 5267–5276. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Κ. Koukoulis Breakdown of academic impact, for papers by Harald Rieder Breakdown of academic impact, for papers by Edwin C. Douglass Breakdown of academic impact, for papers by Hiroko Ikeda Breakdown of academic impact, for papers by Irina A. Lubensky Breakdown of academic impact, for papers by Luca Emanuele Pollina Breakdown of academic impact, for papers by J. Plaschkes Breakdown of academic impact, for papers by József Zsíros Breakdown of academic impact, for papers by Xiang‐Ming Lao Breakdown of academic impact, for papers by Pilar Lardelli
Rankless by CCL
2026